PCN15 COST-EFFECTIVENESS OF NEW TARGETED THERAPY SUNITINIB MALATE AS SECOND LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA IN ARGENTINA
May 1, 2007, 00:00
10.1016/S1098-3015(10)68926-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)68926-7/fulltext
Title :
PCN15 COST-EFFECTIVENESS OF NEW TARGETED THERAPY SUNITINIB MALATE AS SECOND LINE TREATMENT IN METASTATIC RENAL CELL CARCINOMA IN ARGENTINA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)68926-7&doi=10.1016/S1098-3015(10)68926-7
First page :
Section Title :
Open access? :
No
Section Order :
105